There are multiple prescription products that reduce cholesterol levels but do not have an effect on homocysteine levels. FOLMOR™ (folic acid 2.5mg, B6 25mg, B12 2mg and primorine 875mg), a new treatment from Zylera, breaks down homocysteine in the body. Patients benefit from the dual effect of folic acid, combined with Zylera’s Cytac™ technology, thus reducing the risk of developing cardiovascular disease.